INDEPENDENT SERVICERS WOULD BE REQUIRED TO DEVELOP SERVICE AND INSTALLATION PROCESSES TO ENSURE DEVICE CONFORMANCE TO SPECS UNDER HIMA/NEMA PROPOSAL
This article was originally published in The Gray Sheet
Executive Summary
Independent service and repair organizations would have to develop their own service and installation processes to ensure that a device continues to conform to its original specifications under a draft ISRO quality system regulation developed by the Health Industry Manufacturers Association and the National Electrical Manufacturers Association. Under the draft reg, service firms would have to develop and document their own processes when they have not "contractually obtained" procedures established by the device manufacturer.
You may also be interested in...
US FDA Drugs Center Ready To Break Down Silos On Regulatory Innovation
CDER Director Cavazzoni is promising to increase coordination and collaboration to accelerate broader adoption of innovative clinical trial designs and other approaches to speed drug development. A new "Quantitative Medicine Center of Excellence" illustrates the approach.
New OSP Director To Guide CDER-Wide IT Upgrades; System Enhancements Speed ANDA Assessments
Generic Drug Structured Assessment for Bioequivalence launched in 2023 and has been used in 40 ANDA reviews so far.
New EU Approvals
The Pink Sheet's list of EU centralized approvals of new active substances has been updated to add two new products, including Ryzneuta, Evive Biotechnology's treatment for chemotherapy-induced neutropenia.